Cancer Research Annual Meeting 2010  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Greer, D. A.
Right arrow Articles by Davey, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greer, D. A.
Right arrow Articles by Davey, S.
[Cancer Research 63, 4829-4835, August 15, 2003]
© 2003 American Association for Cancer Research


Regular Articles

hRad9 Rapidly Binds DNA Containing Double-Strand Breaks and Is Required for Damage-dependent Topoisomerase IIß Binding Protein 1 Focus Formation1

Deborah A. Greer, Blair D. A. Besley, Katherine B. Kennedy and Scott Davey2

Division of Cancer Biology and Genetics [D. A. G, B. D. A. B., K. B. K., S. D.], and Departments of Pathology [D. A. G., S. D.], Biochemistry [B. D. A. B., S. D.], and Oncology [S. D.], Queen’s University Cancer Research Institute, Kingston, Ontario, K7L 3N6 Canada


    ABSTRACT
 Top
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Checkpoint proteins protect the genomic integrity of a cell, repeatedly impaired by DNA damage and normal cellular processes, such as replication. Checkpoint proteins hRad9, hRad1, and hHus1 form a heterotrimeric complex that is thought to act as a genomic surveyor of DNA damage. We show here that, when DNA double-strand breaks (DSBs) are specifically generated in a subnuclear area, hRad9 is rapidly retained at the damaged DNA, within 2 min of damage induction. Rapid localization of hRad9 to regions of DNA containing DSBs is most efficient during replication. Furthermore, hRad9 colocalizes with the phosphorylated form of damage-response protein H2AX ({gamma}H2AX) after DNA damage. This localization is independent of the damage repair kinase ataxia telangiectasia-mutated kinase (ATM), because hRad9/{gamma}H2AX colocalization still occurs in ATM-/- fibroblasts. Secondly, hRad9 interacts with replication and checkpoint protein topoisomerase IIß binding protein 1 (TopBP1) before and after DNA damage, and this interaction is dependent on the COOH-terminal 17 amino acids of hRad9. Overexpression of a COOH-terminally deleted form of hRad9 abolishes the colocalization of TopBP1 to {gamma}H2AX, ablating TopBP1 but not {gamma}H2AX foci formation. The loss of TopBP1 containing foci, but not of {gamma}H2AX containing foci, indicates that hRad9 is required for TopBP1 focus formation after damage, but is not required for {gamma}H2AX formation at DSBs. These results are consistent with a model in which the hRad9/hHus1/hRad1 complex acts as a checkpoint sensor during S phase by rapidly localizing to sites of DNA damage and transducing checkpoint responses by facilitating proper localization of downstream checkpoint proteins, including TopBP1.


    INTRODUCTION
 Top
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Checkpoint mechanisms have the dual responsibility of sensing DNA damage sites in the genome, and signaling to downstream transducer and effector molecules that target substrates residing largely in the cytoplasm. The G2 checkpoint pathway arrests the cell cycle at the G2-M transition by sensing DNA damage and signaling to Cdc2, a cell cycle-dependent kinase necessary for progression to mitosis (1) . Acting upstream in the checkpoint pathway, hRad9, hRad1, and hHus1 form a nuclear complex that resembles PCNA, and is thought to sense DNA damage (2, 3, 4) . Localization of hRad9 to the nucleus is dependent on a NLS3 (5) located in the hRad9 COOH terminus (5) . Localization of hRad1 to the nucleus is also dependent on the hRad9 NLS, and, subsequently, the NLS is necessary for proper checkpoint activation (5) . Throughout the cell cycle the hRad9/hRad1/hHus1 complex binds chromatin, but it becomes extensively bound to chromatin after DNA damage (6 , 7) . Loading of the hRad9/hRad1/hHus1 complex to chromatin is dependent on the hRad17-replication factor C complex, which resembles the clamp loading complex that loads PCNA onto DNA (8 , 9) . It has been proposed that once the hRad9/hRad1/hHus1 complex is loaded onto DNA, it functions as a genomic surveyor, scanning the genome for DNA damage (4) . However, it has not been formally demonstrated that hRad9/hRad1/hHus1 binds directly to damaged DNA.

H2AX is rapidly phosphorylated ({gamma}H2AX) at DNA DSBs and a wide array of DNA damage and recombinational products (10, 11, 12) . By inducing DSBs in a specific partial nuclear volume, Rogakou et al. (10) were able to demonstrate that H2AX is phosphorylated in discrete regions surrounding damaged DNA, and that these foci formed within 1 min of exposure to DNA damage. Furthermore, localization of 53BP1, BRCA1, and Nbs1 to damage-induced foci is dependent on H2AX (13) , suggesting that rapid phosphorylation of H2AX at damage sites facilitates recruitment of protein complexes necessary for checkpoint activation and repair.

Several proteins, such as TopBP1, may be required for transducing the checkpoint signal to the downstream checkpoint pathway and normal cellular events such as replication. TopBP1 is the human homologue of fission yeast protein Rad4/Cut5, and is required for replication and the replication and damage checkpoints (14, 15, 16, 17, 18, 19) . Genetic experiments in fission yeast suggest that Rad4/Cut5 and Rad9 act upstream in the G2 checkpoint signaling pathway (20) . In human cells, TopBP1 is required for replication, and interacts with DNA polymerase {epsilon}, which participates in damage synthesis (20) . TopBP1 has also been shown to interact with hRad9 by two-hybrid studies and with overexpressed, epitope-tagged hRad9 (20) . Thus, the close association of hRad9 and TopBP1 and their homologues has persisted throughout evolution, and is integral to the DNA damage response.


    MATERIALS AND METHODS
 Top
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Cell Lines, Cell Culture, DNA-damaging Agents and Transfections.
HeLa, IMR-90, and ATM-/- (CRL-7201, ATCC) cells were grown in DMEM (Invitrogen, Burlington, Canada) supplemented with 10% fetal bovine serum (Invitrogen) and antibiotic-antimycotic (Invitrogen) at 37°C in 5% CO2 atmosphere. For DNA damage treatments, cells were exposed to the indicated dose of {gamma}-irradiation, performed with 137Cs in a Victoreen Electrometer (Atomic Energy of Canada), at a dose rate of 0.76 Gy/min. UV irradiations were performed at 254 nm at a dose rate of 2 J/m2s. HU (ICN, Costa Mesa, CA) was used at a final concentration of 2 mM, and BM (Faulding, Montreal, Canada) was used at a final concentration of 1 µg/ml. HeLa cells were transfected as described previously (21) . The Myc-TopBP1 construct was the generous gift of Dr. Junjie Chen (22) . Transfections were performed as described previously (2) . hRad9-EGFP stable cells were generated by transfection of HeLa cells expressing the pTet-Off vector (Clontech, Palo Alto, CA) with pTRE/hRad9-EGFP and pTK-Hyg (Clontech), and selecting clones resistant to hygromycin. Cells were synchronized by single thymidine block as described previously (23) , with the exception that the cells were washed with PBS, and the cells were released into complete DMEM.

Formation DNA DSBs in Partial Nuclear Volumes.
Formation of DNA DSBs was preformed by adapting the methods of Rogakou et al. and Limoli and Ward, as follows (10 , 24) . Live cells stably expressing hRad9-EGFP were grown in delta-T dishes (0.17 mm; Bioptechs, Butler, PA) in the presence of BrdUrd (Cell Proliferation Labeling Reagent, Amersham Biosciences, Piscataway, NJ) for 24 h. Cells were then stained with 1 µg/ml Hoechst dye 33258 where indicated and were overlayed with paraffin oil and were incubated on a heated stage for the duration of the experiment. Cells were visualized using a confocal inverted microscope (Leica TCS SP2 MP inverted Confocal Microscope) using a x100 objective (oil). Localization of hRad9-EGFP was monitored using an Ar/HeNe laser at 488 nm, and emission was measured at 500–535 nm. Using a two-photon laser set at 780 nm, the Hoechst dye was excited in a partial nuclear volume by changing the dimensions of the laser path to a narrow band in the center of the field of view. Immediately after irradiation, the localization of hRad9-GFP was followed for 10 min in 1-min intervals. As a control, cells were also irradiated in the absence of Hoechst dye, which does not induce DNA DSBs when irradiated by the two-photon laser.

Antibodies.
Antibodies used for indirect immunofluorescence experiments were as follows: affinity purified hRad9 chicken polyclonal antibody (2) , {gamma}H2AX (Upstate Biotechnology, Charlottesville, VA), TopBP1 (BD, Franklin Lakes, NJ), and Myc (9E10; Santa Cruz Biotechnology, Santa Cruz, CA). Affinity-purified hRad9 antibodies were diluted to 1:200 for immunofluorescence experiments and 1:500 for Western blotting, and the rest of the antibodies were diluted according to manufacturers’ recommendations. For double-labeling experiments, the following secondary antibodies were used when appropriate at a concentration of 2 µg/ml: goat chicken Alexa Fluor 488 (Molecular Probes, Eugene, OR), goat rabbit Alexa Fluor 488 (Molecular Probes), goat mouse Alexa Fluor 555 (Molecular Probes), and goat antirabbit Alexa Fluor 546 (Molecular Probes).

Indirect Immunofluorescence.
Cells were grown on glass coverslips in six-well tissue culture dishes. At indicated times after damage, cells in Fig. 2Citation were washed twice with PBS and were treated with extraction buffer [50 mM HEPES (pH 7.5), 150 mM NaCl, 1 mM EDTA, 0.5% NP40 (25) ] supplemented with 0.5 mM AEBSF (Bioshop, Burlington, Canada), 20 µg/ml aprotinin, 10 µg/ml leupeptin, 10 µg/ml pepstatin A, 1 mM Na3VO4, 50 mM ß-glycerol phosphate, and 10 mM NaF, for 30 min at 4°C before fixation. In Figs. 3Citation and 4Citation , cells were washed twice with PBS and fixed in 4% paraformaldehyde for 15 min at room temperature, followed by permeabilization in 0.5% Triton-X100 for 10 min at room temperature. In Fig. 5Citation , cells were fixed in methanol/acetone (50:50) for 10 min at room temperature. Cells were then incubated in blocking solution (0.1% Triton-X100, 5% normal goat serum in PBS) for at least 30 min at 4°C. Cells were incubated with the indicated antibodies diluted in blocking solution for 1 h at room temperature, followed by washing three times with wash solution (0.1% Triton-X100 in PBS). Secondary antibodies diluted in blocking solution were then added for an additional 1–2 h, and coverslips were washed as above. 7-aminoactinomycin D (7-AAD; Molecular Probes) was added before mounting when indicated. A drop of glycerol was added to each coverslip, and coverslips were mounted on slides using nail polish.



View larger version (109K):
[in this window]
[in a new window]
[Download PPT slide]
 
Fig. 2. hRad9 colocalizes with {gamma}H2AX at DSBs. Cells were treated with 1 µg/ml BM for 30 min (a) or with 10 Gy IR and were allowed to recover for 8–10 h (b and c). Soluble proteins were extracted, and cells were fixed and incubated with antibodies directed against hRad9 (green) and {gamma}H2AX (red) for immunofluorescent staining. Undamaged (top panel) and damaged (bottom panel) HeLa cells (a), IMR90 cells (b), and ATM-/- cells (c). Merged images are presented in column three; yellow coloring, sites of colocalization. Column 4, enlarged images (x5).

 


View larger version (82K):
[in this window]
[in a new window]
[Download PPT slide]
 
Fig. 3. Endogenous hRad9 interacts with TopBP1. a, HeLa cells were treated with 40 Gy IR and were allowed to recover for 1 h or 18 h as indicated (40 Gy 1hr, and 40 Gy18hr), were treated with 10 mM HU and were allowed to recover for 18 h (10mM HU 18 hr), or left untreated. Cellular lysates were immunoprecipitated with antibodies directed toward hRad9. Immunocomplexes were separated by SDS-PAGE and were analyzed by Western blotting with antibodies directed against hRad9 and TopBP1. hRad9 immunocomplexes contain TopBP1 in the presence and absence of damage. b, HeLa cells, transfected with Myc-TopBP1, were left untreated (-) or were damaged with 1 mM HU (HU), 30 J/m2 UV (UV), or 8 Gy (IR), and were allowed to recover for 6 h. Cells were then fixed and were processed for immunofluorescence staining with antibodies toward hRad9 (green) and TopBP1 (red). Column 3, merged images; yellow coloring, sites of colocalization. Column 4, enlarged images (x5).

 


View larger version (54K):
[in this window]
[in a new window]
[Download PPT slide]
 
Fig. 4. The COOH-terminal 17 amino acids of hRad9 interact with TopBP1. a, schematic diagram of the hRad9 protein, illustrating the position of the COOH-terminal deletion constructs cloned as Myc-tagged fusion proteins, namely myc-hRad9{Delta}59, {Delta}36, {Delta}31, and {Delta}17. Checkered bar, the PCNA-like domain; solid black bar, the NLS. b, HeLa cells were transfected with each of the four hRad9 Myc-tagged COOH-terminal deletion constructs, Myc-tagged hRad9 P5A, or mock transfected. Cellular lysates were immunoprecipitated with antibodies directed toward hRad9. Immunocomplexes were separated by SDS-PAGE and were analyzed by Western blotting with antibodies directed against TopBP1 (top panel) and hRad9 (bottom panel). Each of the deletion constructs demonstrates decreasing mobility because of the deletion of amino acids and lost phosphorylation sites that contribute significantly to the apparent molecular weight of hRad9. Although full-length myc-hRad9 and myc-hRad9 P5A immunocomplexes contain TopBP1, none of the deletion complexes coimmunoprecipitate with TopBP1. c, transfected cells were fixed and incubated with antibodies directed against hRad9 (green) and Myc (red) for indirect immunofluorescence. Column four, merged images; yellow coloring, sites of colocalization. Cells were also stained with 7-AAD, which binds DNA (column 1). Of the hRad9 COOH-terminal deletion constructs, only Myc-hRad9{Delta}17 remains localized to the nucleus.

 


View larger version (65K):
[in this window]
[in a new window]
[Download PPT slide]
 
Fig. 5. Overexpression of hRad9 COOH-terminal deletion constructs abolishes the colocalization of TopBP1 and {gamma}H2AX. a, Myc-tagged hRad9WT, {Delta}59, and {Delta}17 constructs were transfected in IMR90 cells. The cells were then treated 48 h later with 20 Gy {gamma}-radiation and were allowed to recover for 9 h. Cells were then fixed and were immunostained with antibodies directed toward {gamma}H2AX and TopBP1. Images were collected and analyzed for {gamma}H2AX and TopBP1 colocalization by counting the number of foci that were yellow in color in the overlayed image. b, the distribution of the number of colocalized foci per cell is plotted. Solid black bars, hRad9WT (n = 47 cells); solid white bars, hRad9{Delta}59 (n = 50 cells); checkered bars, hRad9{Delta}17 (n = 45 cells).

 
Cells were visualized using a confocal inverted microscope (Leica TCS SP2 MP inverted Confocal Microscope) using a x100 objective (oil). {alpha}-Chicken Alexa Fluor 488 was excited at 488 nm, and the emission was measured at 500–535 nm, {alpha}-rabbit Alexa Fluor 546 and {alpha}-mouse Alexa Fluor 555 were excited at 514 nm and the emission was measured at 556–618 nm. Images were captured sequentially, so as to minimize signal overlapping, and were processed and merged using PhotoShop (Adobe, San Jose, CA). In Fig. 5Citation , merged images were reset using a threshold that read only colocalized foci (yellow), and the number of colocalized foci per cell was counted using Image J (NIH, Bethesda, Maryland).

Immunoprecipitations and Immunoblotting.
Cells were grown in 10-cm tissue-culture dishes and were washed two times with PBS, were lysed in NETN buffer [150 mM NaCl, 1 mM EDTA, 20 mM Tris-HCl, 0.5% NP40 (pH 8.0)] supplemented with 0.5 mM AEBSF, 20 µg/ml aprotinin, 10 µg/ml leupeptin, 10 µg/ml pepstatin A, 1 mM Na3VO4, 50 mM ß-glycerol phosphate, and 10 mM NaF, and were removed by scraping. Lysates were incubated on ice for 30 min and then were centrifuged at 16,000 x g for 10 min at 4°C. Soluble supernatants were precleared with either {alpha}-IgY agarose (Promega, Madison, WI) or protein G Sepharose (Amersham, Piscataway, NJ) for 30–60 min at 4°C on an orbital shaker. Immunoprecipitations were conducted with 20 µl of affinity-purified {alpha}-hRad9 chicken polyclonal antibody with 20 µl of {alpha}-IgY agarose or 2 µg of {alpha}-Myc monoclonal antibody with 15 µl of protein G Sepharose, overnight at 4°C. Immunocomplexes were collected for 2 h at 4°C on an orbital shaker. Immunoprecipitated proteins were washed once with 800 µl of NETN buffer and three times with 800 µl of PBS. Samples were then resuspended in 50 µl of 1.5x SDS-PAGE sample buffer, and heated to 95°C for 5 min.

Samples for immunoblotting were treated as described previously (21) with the exception that horseradish peroxidase-conjugated {alpha}-mouse (The Jackson Laboratory, West Grove, PA) secondary antibodies were used for Myc and TopBP1 Western blots.


    RESULTS
 Top
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
hRad9 Rapidly Localizes to DNA Containing DSBs, and Colocalizes with {gamma}H2AX after DNA Damage.
To determine whether hRad9 localizes to sites of DNA damage, cells expressing hRad9-EGFP were grown in the presence of BrdUrd, and analyzed by confocal microscopy as living cells. hRad9-EGFP localized to the nucleus (Fig. 1)Citation , which is consistent with earlier experiments performed by indirect immunofluorescence (2) . In the presence of BrdUrd, excitation of Hoechst dye generates DNA DSB (24) . DNA DSB were generated in a partial nuclear area by irradiating a narrow band of the nucleus with a two-photon laser at 780 nm, exciting the Hoechst dye (indicated by the arrow in Fig. 1Citation ). Within 1–2 min of DNA DSB formation, hRad9-EGFP preferentially localized to the damaged DNA and accumulated in a bright band coincident with the laser path (Fig. 1Citation , column 3). hRad9-EGFP continued to accumulate to the DNA containing DSBs for 5 min after damage (Fig. 1)Citation and remained associated for at least 20 min after damage. Progressive photobleaching of all of the images was observed over time. Localization of hRad9-EGFP to the subnuclear area along the laser path was dependent on the Hoechst dye (Fig. 1Citation , column 1), suggesting that it is dependent on the formation of DNA DSBs. Even in the presence of Hoechst, however, rapid (<2 min) localization of hRad9-EGFP to the damaged DNA occurred only in 30% of cells growing asynchronously (Fig. 1Citation , compare column 3 and 4). To investigate whether localization of hRad9-EGFP to DNA containing a DSB occurs only in a cell cycle subpopulation of cells, we synchronized cells to S phase by single thymidine block and release. hRad9-EGFP localization to DNA containing a DSB was apparent within 2 min of damage in >70% of S-phase cells (Fig. 1Citation , column 2), suggesting that the function of hRad9 in sensing DNA damage may be acting preferentially during DNA replication.



View larger version (99K):
[in this window]
[in a new window]
[Download PPT slide]
 
Fig. 1. hRad9 rapidly localizes to DNA DSB during replication. HeLa cells expressing hRad9-EGFP were grown asynchronously (A) or synchronized to S phase (S) and were analyzed as living cells by confocal microscopy (row 1). DNA DSBs were generated in a partial nuclear area as described in "Materials and Methods" (row 2, arrow) in the presence and absence of Hoechst dye. Images were captured immediately after DNA DSB formation (row 3), and at 1-min intervals for the next 5 min (rows 4–8).

 
As an alternative method of demonstrating the localization of hRad9 to DNA containing a DSB, we have examined the colocalization of hRad9 and {gamma}H2AX by indirect immunofluorescence in fixed cells. DNA damage induces the phosphorylation of H2AX ({gamma}H2AX) in the region surrounding DSBs (10 , 26) . Many proteins have been found to colocalize with {gamma}H2AX after DNA damage, including 53BP1, MDC1, and TopBP1 (27, 28, 29) . To determine whether hRad9 also colocalizes with {gamma}H2AX after damage, cells were damaged with BM and IR to induce DSBs. Indirect immunofluorescence analysis demonstrates that hRad9 forms extraction-resistant foci, which are enhanced by DNA damage (Fig. 2Citation , column 1). When cells were synchronized to late S-G2 phase, formation of DNA DSBs by BM resulted in colocalization of hRad9 with {gamma}H2AX foci within 30 min, in ~60% of cells (Fig. 2a)Citation . In asynchronous cells, after 8–10 h of recovery from DNA damage, {gamma}H2AX foci emerged at sites of DSBs in larger, more diffuse foci known to encompass megabase domains of DNA (10) . These foci largely colocalized with hRad9 foci, in ~80% of cells (Fig. 2b)Citation . These results confirm the live-cell studies (Fig. 1)Citation , indicating that hRad9 colocalizes with {gamma}H2AX at sites of DNA containing DSBs and also that it can remain associated at long-time points after damage.

H2AX is phosphorylated by ATM and ATR after DNA damage, but localization to DSB is not dependent on this phosphorylation (12 , 30 , 31) . Whereas hRad9 is constitutively phosphorylated at multiple residues throughout the normal cell cycle, it becomes hyperphosphorylated after damage at serine 272 by ATM (21 , 32) . ATM-dependent phosphorylation of hRad9 is required for checkpoint activation but not for chromatin binding (7 , 21 , 32) . Therefore, we wondered whether hRad9 would still colocalize with {gamma}H2AX in AT cells that do not express functional ATM. After {gamma}-radiation treatment, {gamma}H2AX foci colocalized with hRad9 foci in 40% of AT cells, indicating that phosphorylation of hRad9 by ATM is not required for hRad9 localization to DNA containing DSBs (Fig. 2c)Citation . These results are consistent with experiments performed in Saccharomyces cerevisiae, which showed that the hRad9 budding yeast homologue Ddc1 localizes to damaged DNA independently of the ATM homologue Mec1 (33 , 34) .

hRad9 Interaction with TopBP1 Is Dependent on the hRad9 COOH Terminus.
We next wanted to look at transducers of the checkpoint downstream of hRad9 that also form damage-dependent foci. TopBP1 colocalizes to {gamma}H2AX foci after DNA damage and was shown to interact with epitope-tagged hRad9 (20 , 29) . We, therefore, wanted to know whether TopBP1 associates with endogenous hRad9. As shown in Fig. 3aCitation , endogenous TopBP1 coimmunoprecipitated with hRad9 antibodies. The interaction persisted after DNA damage and after HU treatment, which stalled replication fork progression in S-phase cells. Indirect immunofluorescence showed that in cells transfected with Myc-TopBP1, hRad9 also colocalized with TopBP1 in ~70% of cells (Fig. 3b)Citation , but this colocalization was most apparent after treatment with HU, suggesting that this interaction may be especially important in S-phase cells.

Because TopBP1 is able to interact with the COOH-terminal 148 amino acids of hRad9 by yeast two-hybrid analysis, we generated hRad9 deletion constructs to determine which domain of hRad9 interacts with TopBP1 (20) . The deletion constructs eliminated the final 59, 36, 31, and 17 amino acids of hRad9, respectively (Fig. 4a)Citation . Each of these constructs and full length hRad9 was tagged with the Myc epitope to distinguish endogenous and transfected hRad9. In coimmunoprecipitation experiments of cells transiently transfected with the Myc-hRad9 constructs, only full-length Myc-tagged hRad9 was able to coimmunoprecipitate with TopBP1 (Fig. 4b)Citation . None of the deletion constructs were able to interact with TopBP1. However, because three of the four deletion constructs fully or partially eliminated the NLS of hRad9, we tested to see whether the interaction was abolished simply because hRad9 was sequestered from the nucleus. Cells transiently transfected with Myc-hRad9 WT exhibited nuclear colocalization with endogenous hRad9 (Fig. 4c)Citation . Myc-hRad9{Delta}31, {Delta}36, and {Delta}59 constructs failed to localize discretely to the nucleus and were dispersed more extensively throughout the cytoplasm as more of the COOH terminus was removed. Myc-hRad9{Delta}17, which contains an intact NLS, however, did localize to the nucleus. Therefore, Myc-hRad9 {Delta}17 failed to coimmunoprecipitate with TopBP1 despite its nuclear localization. These results suggest that the final 17 amino acids of hRad9 are important for its interaction with TopBP1. Additionally, Myc-hRad9 P5A, which contains five serine/threonine mutations at hRad9 phosphorylation sites (2) , bound TopBP1 with a reduced affinity. This suggests that the interaction may be regulated in part by these phosphorylation events.

DNA Damage-dependent Focus Formation of TopBP1 Is Dependent on hRad9.
TopBP1 contains eight BRCT domains, which are common in checkpoint and DNA repair proteins for mediating protein-protein interactions and DNA binding (35) . TopBP1 BRCT domains 4 and 5 were shown to directly interact with hRad9 in yeast two-hybrid analysis (20) . Furthermore, TopBP1 BRCT 5 is required for formation of TopBP1 containing foci after DNA damage (22) . Taken together, these results suggest that the TopBP1 interaction with hRad9 may be required to localize TopBP1 to sites of DNA damage. To test this hypothesis, we transfected cells with hRad9WT, {Delta}59, or {Delta}17 constructs, and measured the number of TopBP1 foci that colocalized with {gamma}H2AX after DNA damage. The transfection efficiency was >40% in all cases, based on the number of GFP positives in a concurrent experiment. The number of TopBP1 foci that colocalized with {gamma}H2AX per cell was counted, and the frequency of the number of foci/cell was plotted and analyzed (Fig. 5)Citation . In cells transfected with hRad9WT, TopBP1 significantly colocalized with {gamma}H2AX, with a median of 13 colocalized foci/cell. In contrast, in cells transfected with hRad9{Delta}59, the number of TopBP1/{gamma}H2AX colocalized foci per cell was markedly less, with a median of 2 colocalized foci/cell. The lack of colocalization between TopBP1 and {gamma}H2AX was attributable to a significant reduction in the number of TopBP1 foci that formed, rather than a decrease in the number of TopBP1 foci that overlayed with {gamma}H2AX (Fig. 5a)Citation . Similar results were demonstrated for hRad9{Delta}17, with a median of 3 colocalized foci/cell. More than one-half of the hRad9{Delta}59 and {Delta}17 transfected cells had <3 colocalized foci/cell, whereas none of the hRad9WT transfected cells had <3 colocalized foci/cell (Fig. 5b)Citation . This indicates that overexpression of hRad9{Delta}59 and {Delta}17 abolishes the damage-dependent focus formation of TopBP1.


    DISCUSSION
 Top
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
We have shown that overexpression of hRad9 COOH-terminal mutants abolishes the formation of TopBP1 damage-dependent foci, indicating that hRad9 is required for proper functioning of TopBP1 damage responses. Much of the hRad9 COOH terminus is removed in the {Delta}59 mutant, including the NLS, leaving only the PCNA-like domain and the first one-half of the COOH terminus. This construct is, however, sufficient for interaction with hRad1 and hHus1 (data not shown). Similar hRad9 constructs have been shown to act as dominant negatives (36) , because most of the cellular pool of hRad1 and hHus1 that bind this domain is recruited to the cytoplasm. Thus, hRad9{Delta}59 is likely abolishing the formation of the TopBP1 foci by sequestering hRad1 and hHus1 in the cytoplasm, and prohibiting the hRad9/hRad1/hHus1 complex from localizing to sites of DNA containing DSBs. In the case of hRad9{Delta}17, which resides in the nucleus and binds hRad1 and hHus1 but lacks the TopBP1-binding domain, a similar phenotype is observed. This demonstrates that abolishing the interaction between hRad9 and TopBP1 is sufficient to disrupt TopBP1 containing foci after DNA damage. Taken together, these data suggest that the hRad9 COOH terminus targets TopBP1 to damage sites.

We have also demonstrated that hRad9 is localized to sites of DNA containing DSBs. Whereas other groups have previously shown that hRad9 is retained at chromatin after DNA damage (6) , we are able to show that hRad9 is localized specifically to DNA containing a DSB by rapid localization of hRad9-EGFP to a specific subnuclear area of DNA damage, and colocalization of hRad9 with the damage-induced phosphorylated form of H2AX. After DNA damage, virtually all of the {gamma}H2AX containing foci also contain hRad9, although the converse is not true. We have observed similar relationships between hRad9 containing foci and those containing other damage response proteins.4 The additional hRad9 foci likely results from an excess of nuclear hRad9, but we cannot rule out the possibility that they represent the association of hRad9 with some form of endogenous DNA damage.

Localization of hRad9 to DSBs and colocalization with {gamma}H2AX occurs rapidly in S-phase cells. Studies using cell-free Xenopus extracts have suggested that the binding of XHus1 to chromatin is dependent on DNA polymerase {alpha} (37) , suggesting that hRad9/hRad1/hHus1 acts as sensor of DNA damage during replication. Others have shown, however, that hRad9 binds chromatin after damage in G1 (7) , although we do not observe hRad9-EGFP accumulation at DNA DSBs in the majority of asynchronous cells, which are ~60% G1 phase. It may be that, although hRad9/hRad1/hHus1 is binding to chromatin during G1 phase after DNA damage, we do not observe accumulation of hRad9-EGFP after damage because hRad9 is not competent within this very rapid time period (5 min or less) to localize to the damaged DNA. Phosphorylation of specific hRad9 residues during S phase may enable hRad9 to bind to DNA DSBs very rapidly, and, indeed, we have previously reported a distinct hRad9 phosphorylation that occurs exclusively in G2-M phase cells (21) .

In asynchronous cells, hRad9 colocalized to {gamma}H2AX after long periods of recovery from DNA damage. Approximately 8–12 h after DNA damage, many damage response and repair proteins, including {gamma}H2AX, are known to localize to IR-induced foci (IRIF). However, because repair is expected to be completed by this time frame, it has been suggested that these foci represent irreparable sections of DNA in which damage repair proteins have amassed (38) .

We have also shown here that hRad9 localizes to DNA containing DSBs independently of ATM. This result is consistent with experiments performed in S. cerevisiae, illustrating that hRad9/hRad1/hHus1 homologues Ddc1/Rad17/Mec3 and ATR/ATRIP homologues Mec1/Ddc2 localize independently to damage sites (33 , 34) . Additionally, the damage-induced phosphorylation of hRad17 by ATR is dependent on the hHus1 binding to chromatin, presumably at sites of damage (8) . Thus, our finding that hRad9 localizes to DSB independently of ATM supports a model in which the hRad9/hRad1/hHus1 complex is localized independently to DNA damage sites.

Modeling of hRad9/hRad1/hHus1 to a PCNA-like complex has led to the suggestion that this complex acts as a landing platform for other repair and checkpoint proteins to sites of damaged DNA (4) . Localization of hRad9 to sites of DNA damage implicates the hRad9/hRad1/hHus1 complex as an immediate sensor of structural changes in DNA during replication. In this model, TopBP1 may be an example of hRad9/hRad1/hHus1-dependent recruitment of checkpoint and repair proteins to damage sites. TopBP1 and other checkpoint and repair proteins may then be phosphorylated by ATR/ATM, which independently localize to DNA damage. Indeed, localization to DNA damage may be required for the ATM-dependent phosphorylation of hRad9 after DNA damage, because localization to DNA damage sites is independent of ATM. TopBP1 recruitment to the hRad9/hRad1/hHus1 complex by hRad9 at sites of DNA damage may be an important function of the DNA damage checkpoint, because TopBP1 contains multiple BRCT domains that are capable of interacting with other BRCT domains containing proteins (39) . Thus, localization of the hRad9/hRad1/hHus1 complex to DNA damage sites may nucleate the many protein-protein interactions necessary for checkpoint activation and DNA repair.


    ACKNOWLEDGMENTS
 
We thank Derek Schulze and Jeff Mewburn for assistance with confocal microscopy, Dr. Junjie Chen, Mayo Clinic and Foundation, Rochester, MN, for the generous gift of the Myc-TopBP1 construct, and Lee Fraser and Bob St. Onge for critically reading the manuscript.


    FOOTNOTES
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Supported by Canadian Institutes of Health Research (CIHR) Grants MOP-14352 and MOP-36526 (to S. D.) The confocal microscope was purchased with funding from the Canadian Foundation for Innovation (CFI) and the Ontario Innovation Trust (OIT) for the Protein Function Discovery Facility. Confocal microscopy was funded in part by CIHR Mult-User Equipment and Maintenance Grant MT-7827. S. D. is a Cancer Care Ontario Scientist. D. A. G. is a recipient of a Natural Sciences and Engineering Research Council of Canada studentship. B. D. A. B. is a recipient of a United States Army Breast Cancer Research Studentship DAMD1798-1-8080. Back

2 To whom requests for reprints should be addressed, at Division of Cancer Biology and Genetics, Queen’s University Cancer Research Institute, Botterell Hall Room 364, Queen’s University, Kingston, Ontario, K7L 3N6 Canada. Phone: 613-533-6923; Fax: 613-533-6830; E-mail: sd13{at}post.queensu.ca Back

3 The abbreviations used are: NLS, nuclear localization signal; AT, ataxia telangiectasia; ATM, AT-mutated kinase; ATR, ATM- and Rad3-related; BM, bleomycin; BRCT, BRCA1 COOH-terminal; BrdUrd, bromodeoxyuridine; DSB, double-strand break; GFP, green fluorescent protein; EGFP, enhanced GFP; HU, hydroxyurea; IR, ionizing radiation; TopBP1, topoisomerase IIß binding protein 1; PCNA, proliferating cell nuclear antigen; WT, wild type; {gamma}H2AX, phosphorylated H2AX; AEBSF, 4-(2-aminoethyl)-benzenesulfonylflurode.HCl; 53BP1, p53 binding protein 1. Back

4 D. A. G. and S. D., unpublished observations. Back

Received 12/18/02. Revised 4/16/03. Accepted 6/ 6/03.


    REFERENCES
 Top
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Nyberg K. A., Michelson R. J., Putnam C. W., Weinert T. A. Toward maintaining the genome: DNA damage and replication checkpoints. Annu. Rev. Genet., 36: 617-656, 2002.[Medline]
  2. St. Onge R. P., Udell C. M., Casselman R., Davey S. The human G2 checkpoint control protein hRAD9 is a nuclear phosphoprotein that forms complexes with hRAD1 and hHUS1. Mol. Biol. Cell, 10: 1985-1995, 1999.[Abstract/Free Full Text]
  3. Volkmer E., Karnitz L. M. Human homologs of Schizosaccharomyces pombe rad1, hus1, and rad9 form a DNA damage-responsive protein complex. J. Biol. Chem., 274: 567-570, 1999.[Abstract/Free Full Text]
  4. Venclovas C., Thelen M. P. Structure-based predictions of Rad1. Rad9, Hus1 and Rad17 participation in sliding clamp and clamp-loading complexes. Nucleic Acids Res., 28: 2481-2493, 2000.[Abstract/Free Full Text]
  5. Hirai I., Wang H. G. A role of the C-terminal region of human Rad9 (hRad9) in nuclear transport of the hRad9 checkpoint complex. J. Biol. Chem., 277: 25722-25727, 2002.[Abstract/Free Full Text]
  6. Burtelow M. A., Kaufmann S. H., Karnitz L. M. Retention of the hRad9 checkpoint complex in extraction-resistant nuclear complexes after DNA damage. J. Biol. Chem., 275: 26343-26348, 2000.[Abstract/Free Full Text]
  7. Roos-Mattjus P., Vroman B. T., Burtelow M. A., Rauen M., Eapen A. K., Karnitz L. M. Genotoxin-induced Rad9-Hus1-Rad1 (9-1-1) chromatin association is an early checkpoint signaling event. J. Biol. Chem., 277: 43809-43812, 2002.[Abstract/Free Full Text]
  8. Zou L., Cortez D., Elledge S. J. Regulation of ATR substrate selection by Rad17-dependent loading of Rad9 complexes onto chromatin. Genes Dev., 16: 198-208, 2002.[Abstract/Free Full Text]
  9. Bermudez V. P., Lindsey-Boltz L. A., Cesare A. J., Maniwa Y., Griffith J. D., Hurwitz J., Sancar A. Loading of the human 9-1-1 checkpoint complex onto DNA by the checkpoint clamp loader hRad17-replication factor C complex in vitro. Proc. Natl. Acad. Sci. USA, 100: 1633-1638, 2003.[Abstract/Free Full Text]
  10. Rogakou E. P., Boon C., Redon C., Bonner W. M. Megabase chromatin domains involved in DNA DSB in vivo. J. Cell Biol., 146: 905-916, 1999.[Abstract/Free Full Text]
  11. Furuta T., Takemura H., Liao Z. Y., Aune G. J., Redon C., Sedelnikova O. A., Pilch D. R., Rogakou E. P., Celeste A., Chen H. T., et al Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexes. J. Biol. Chem., 278(22): 20303-20312, 2003.[Abstract/Free Full Text]
  12. Ward I. M., Chen J. Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J. Biol. Chem., 276: 47759-47762, 2001.[Abstract/Free Full Text]
  13. Celeste A., Petersen S., Romanienko P. J., Fernandez-Capetillo O., Chen H. T., Sedelnikova O. A., Reina-San-Martin B., Coppola V., Meffre E., Difilippantonio M. J., Redon C., Pilch D. R., Olaru A., Eckhaus M., Camerini-Otero R. D., Tessarollo L., Livak F., Manova K., Bonner W. M., Nussenzweig M. C., Nussenzweig A. Genomic instability in mice lacking histone H2AX. Science (Wash. DC), 296: 922-927, 2002.[Abstract/Free Full Text]
  14. Fenech M., Carr A. M., Murray J., Watts F. Z., Lehmann A. R. Cloning and characterization of the rad4 gene of Schizosaccharomyces pombe: a gene showing short regions of sequence similarity to the human XRCC1 gene. Nucleic Acids Res., 19: 6737-6741, 1991.[Abstract/Free Full Text]
  15. McFarlane R. J., Carr A. M., Price C. Characterisation of the Schizosaccharomyces pombe rad4/cut5 mutant phenotypes: dissection of DNA replication and G2 checkpoint control function. Mol. Gen. Genet., 255: 332-340, 1997.[Medline]
  16. Saka Y., Fantes P., Yanagida M. Coupling of DNA replication and mitosis by fission yeast rad4/cut5. J. Cell Sci. Suppl., 18: 57-61, 1994.[Medline]
  17. Saka Y., Yanagida M. Fission yeast cut5+, required for S phase onset and M phase restraint, is identical to the radiation-damage repair gene rad4+ [see comments]. Cell, 74: 383-393, 1993.[Medline]
  18. Saka Y., Fantes P., Sutani T., McInerny C., Creanor J., Yanagida M. Fission yeast cut5 links nuclear chromatin and M phase regulator in the replication checkpoint control. EMBO J., 13: 5319-5329, 1994.[Medline]
  19. Marchetti M. A., Kumar S., Hartsuiker E., Maftahi M., Carr A. M., Freyer G. A., Burhans W. C., Huberman J. A. A single unbranched S-phase DNA damage and replication fork blockage checkpoint pathway, Proc. Natl. Acad. Sci. USA, 99: 7472-7477, 2002.[Abstract/Free Full Text]
  20. Makiniemi M., Hillukkala T., Tuusa J., Reini K., Vaara M., Huang D., Pospiech H., Majuri I., Westerling T., Makela T. P., Syvaoja J. E. BRCT domain-containing protein TopBP1 functions in DNA replication and damage response. J. Biol. Chem., 276: 30399-30406, 2001.[Abstract/Free Full Text]
  21. St Onge R. P., Besley B. D., Park M., Casselman R., Davey S. DNA damage-dependent and -independent phosphorylation of the hRad9 checkpoint protein. J. Biol. Chem., 276: 41898-41905, 2001.[Abstract/Free Full Text]
  22. Yamane K., Wu X., Chen J. A DNA damage-regulated BRCT-containing protein, TopBP1, is required for cell survival. Mol. Cell. Biol., 22: 555-566, 2002.[Abstract/Free Full Text]
  23. Jakesz R., Smith C. A., Aitken S., Huff K., Schuette W., Shackney S., Lippman M. Influence of cell proliferation and cell cycle phase on expression of estrogen receptor in MCF-7 breast cancer cells. Cancer Res., 44: 619-625, 1984.[Abstract/Free Full Text]
  24. Limoli C. L., Ward J. F. A new method for introducing DSB into cellular DNA. Radiat. Res., 134: 160-169, 1993.[Medline]
  25. Andegeko Y., Moyal L., Mittelman L., Tsarfaty I., Shiloh Y., Rotman G. Nuclear retention of ATM at sites of DNA double strand breaks. J. Biol. Chem., 276: 38224-38230, 2001.[Abstract/Free Full Text]
  26. Rogakou E. P., Pilch D. R., Orr A. H., Ivanova V. S., Bonner W. M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem., 273: 5858-5868, 1998.[Abstract/Free Full Text]
  27. Schultz L. B., Chehab N. H., Malikzay A., Halazonetis T. D. p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA DSB, J. Cell Biol., 151: 1381-1390, 2000.
  28. Stewart G. S., Wang B., Bignell C. R., Taylor A. M., Elledge S. J. MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature (Lond.), 421: 961-966, 2003.[Medline]
  29. Honda Y., Tojo M., Matsuzaki K., Anan T., Matsumoto M., Ando M., Saya H., Nakao M. Cooperation of HECT-domain ubiquitin ligase hHYD and DNA topoisomerase II-binding protein for DNA damage response. J. Biol. Chem., 277: 3599-3605, 2002.[Abstract/Free Full Text]
  30. Burma S., Chen B. P., Murphy M., Kurimasa A., Chen D. J. ATM phosphorylates histone H2AX in response to DNA DSB. J. Biol. Chem., 276: 42462-42467, 2001.[Abstract/Free Full Text]
  31. Siino J., Nazarov I., Zalenskaya I., Yau P., Bradbury E., Tomilin N. End-joining of reconstituted histone H2AX-containing chromatin in vitro by soluble nuclear proteins from human cells. FEBS Lett., 527: 105-108, 2002.[Medline]
  32. Chen M. J., Lin Y. T., Lieberman H. B., Chen G., Lee E. Y. Atm-dependent phosphorylation of human rad9 is required for ionizing radiation-induced checkpoint activation. J. Biol. Chem., 276: 16580-16586, 2001.[Abstract/Free Full Text]
  33. Melo J. A., Cohen J., Toczyski D. P. Two checkpoint complexes are independently recruited to sites of DNA damage in vivo. Genes Dev., 15: 2809-2821, 2001.[Abstract/Free Full Text]
  34. Kondo T., Wakayama T., Naiki T., Matsumoto K., Sugimoto K. Recruitment of Mec1 and Ddc1 checkpoint proteins to DSB through distinct mechanisms. Science (Wash. DC), 294: 867-870, 2001.[Abstract/Free Full Text]
  35. Yamane K., Kawabata M., Tsuruo T. A DNA-topoisomerase-II-binding protein with eight repeating regions similar to DNA-repair enzymes and to a cell-cycle regulator. Eur. J. Biochem., 250: 794-799, 1997.[Medline]
  36. Kaur R., Kostrub C. F., Enoch T. Structure-function analysis of fission yeast Hus1-Rad1-Rad9 checkpoint complex. Mol. Biol. Cell, 12: 3744-3758, 2001.[Abstract/Free Full Text]
  37. You Z., Kong L., Newport J. The role of single-stranded DNA and polymerase {alpha} in establishing the ATR. Hus1 DNA replication checkpoint. J. Biol. Chem., 277: 27088-27093, 2002.[Abstract/Free Full Text]
  38. Mirzoeva O. K., Petrini J. H. DNA damage-dependent nuclear dynamics of the Mre11 complex, Mol. Cell. Biol., 21: 281-288, 2001.
  39. Bork P., Hofmann K., Bucher P., Neuwald A. F., Altschul S. F., Koonin E. V. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB J., 11: 68-76, 1997.[Abstract]



This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
E. Sjottem, C. Rekdal, G. Svineng, S. S. Johnsen, H. Klenow, R. D. Uglehus, and T. Johansen
The ePHD protein SPBP interacts with TopBP1 and together they co-operate to stimulate Ets1-mediated transcription
Nucleic Acids Res., October 8, 2007; 35(19): 6648 - 6662.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Lee, A. Kumagai, and W. G. Dunphy
The Rad9-Hus1-Rad1 Checkpoint Clamp Regulates Interaction of TopBP1 with ATR
J. Biol. Chem., September 21, 2007; 282(38): 28036 - 28044.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Jeon, K. Y. Lee, M. J. Ko, Y. S. Lee, S. Kang, and D. S. Hwang
Human TopBP1 Participates in Cyclin E/CDK2 Activation and Preinitiation Complex Assembly during G1/S Transition
J. Biol. Chem., May 18, 2007; 282(20): 14882 - 14890.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. L. Ball, M. R. Ehrhardt, D. A. Mordes, G. G. Glick, W. J. Chazin, and D. Cortez
Function of a Conserved Checkpoint Recruitment Domain in ATRIP Proteins
Mol. Cell. Biol., May 1, 2007; 27(9): 3367 - 3377.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
H. Ogiwara, A. Ui, F. Onoda, S. Tada, T. Enomoto, and M. Seki
Dpb11, the budding yeast homolog of TopBP1, functions with the checkpoint clamp in recombination repair
Nucleic Acids Res., July 13, 2006; 34(11): 3389 - 3398.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
P. J. Lupardus and K. A. Cimprich
Phosphorylation of Xenopus Rad1 and Hus1 Defines a Readout for ATR Activation That Is Independent of Claspin and the Rad9 Carboxy Terminus
Mol. Biol. Cell, April 1, 2006; 17(4): 1559 - 1569.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. K. Pandita, G. G. Sharma, A. Laszlo, K. M. Hopkins, S. Davey, M. Chakhparonian, A. Gupta, R. J. Wellinger, J. Zhang, S. N. Powell, et al.
Mammalian rad9 plays a role in telomere stability, s- and g2-phase-specific cell survival, and homologous recombinational repair.
Mol. Cell. Biol., March 1, 2006; 26(5): 1850 - 1864.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. B. Smilenov, H. B. Lieberman, S. A. Mitchell, R. A. Baker, K. M. Hopkins, and E. J. Hall
Combined Haploinsufficiency for ATM and RAD9 as a Factor in Cell Transformation, Apoptosis, and DNA Lesion Repair Dynamics
Cancer Res., February 1, 2005; 65(3): 933 - 938.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Jurvansuu, K. Raj, A. Stasiak, and P. Beard
Viral Transport of DNA Damage That Mimics a Stalled Replication Fork
J. Virol., January 1, 2005; 79(1): 569 - 580.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Yin, A. Zhu, Y. J. Jin, Y.-X. Liu, X. Zhang, K. M. Hopkins, and H. B. Lieberman
Human RAD9 checkpoint control/proapoptotic protein can activate transcription of p21
PNAS, June 15, 2004; 101(24): 8864 - 8869.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. Wang, C.-L. Hsu, J. Ni, P.-H. Wang, S. Yeh, P. Keng, and C. Chang
Human Checkpoint Protein hRad9 Functions as a Negative Coregulator To Repress Androgen Receptor Transactivation in Prostate Cancer Cells
Mol. Cell. Biol., March 1, 2004; 24(5): 2202 - 2213.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Greer, D. A.
Right arrow Articles by Davey, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greer, D. A.
Right arrow Articles by Davey, S.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online